{"id":"https://openalex.org/W4286742004","doi":"https://doi.org/10.1038/s41467-022-31926-9","title":"Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment","display_name":"Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-23","ids":{"openalex":"https://openalex.org/W4286742004","doi":"https://doi.org/10.1038/s41467-022-31926-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/35871223","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9308817"},"language":"en","primary_location":{"id":"doi:10.1038/s41467-022-31926-9","doi":"https://doi.org/10.1038/s41467-022-31926-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-31926-9","pdf_url":"https://www.nature.com/articles/s41467-022-31926-9.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4286742004"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41467-022-31926-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010288220","display_name":"Moataz M. Reda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Moataz Reda","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003878610","display_name":"Worapol Ngamcherdtrakul","orcid":"https://orcid.org/0000-0003-4187-7709","observed_orcids":["https://orcid.org/0000-0003-4187-7709"]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Worapol Ngamcherdtrakul","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056589923","display_name":"Molly A. Nelson","orcid":"https://orcid.org/0000-0002-3775-3503","observed_orcids":["https://orcid.org/0000-0002-3775-3503"]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Molly A. Nelson","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023105214","display_name":"Natnaree Siriwon","orcid":"https://orcid.org/0000-0002-4130-855X","observed_orcids":["https://orcid.org/0000-0002-4130-855X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Natnaree Siriwon","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100777473","display_name":"Ruijie Wang","orcid":"https://orcid.org/0000-0001-9611-4974","observed_orcids":["https://orcid.org/0000-0001-9611-4974"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruijie Wang","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029152724","display_name":"Husam Y. Zaidan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Husam Y. Zaidan","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050678264","display_name":"Daniel S. Bejan","orcid":"https://orcid.org/0000-0002-5090-0299","observed_orcids":["https://orcid.org/0000-0002-5090-0299"]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel S. Bejan","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038908810","display_name":"Sherif Reda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sherif Reda","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013388193","display_name":"Ngoc Ha Hoang","orcid":"https://orcid.org/0000-0002-2485-4073","observed_orcids":["https://orcid.org/0000-0002-2485-4073"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ngoc Ha Hoang","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032485708","display_name":"Noah A. Crumrine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noah A. Crumrine","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058185006","display_name":"Justin P. C. Rehwaldt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150350","display_name":"PDX Pharmaceuticals (United States)","ror":"https://ror.org/05msdft16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150350"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Justin P. C. Rehwaldt","raw_affiliation_strings":["PDX Pharmaceuticals, Inc., Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA","institution_ids":["https://openalex.org/I4210150350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031226205","display_name":"Akash Bindal","orcid":"https://orcid.org/0000-0002-9834-6979","observed_orcids":["https://orcid.org/0000-0002-9834-6979"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akash Bindal","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":"https://orcid.org/0000-0002-9834-6979","affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gordon B. Mills","raw_affiliation_strings":["Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA","Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":"https://orcid.org/0000-0002-0144-9614","affiliations":[{"raw_affiliation_string":"Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028899187","display_name":"Joe W. Gray","orcid":"https://orcid.org/0000-0001-9225-6756","observed_orcids":["https://orcid.org/0000-0001-9225-6756"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joe W. Gray","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":"https://orcid.org/0000-0001-9225-6756","affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083234239","display_name":"Wassana Yantasee","orcid":"https://orcid.org/0000-0002-0989-363X","observed_orcids":["https://orcid.org/0000-0002-0989-363X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Wassana Yantasee","raw_affiliation_strings":["Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. yantasee@ohsu.edu","Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. yantasee@ohsu.edu","PDX Pharmaceuticals, Inc., Portland, OR, USA. yantasee@ohsu.edu","Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":"https://orcid.org/0000-0002-0989-363X","affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. yantasee@ohsu.edu","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. yantasee@ohsu.edu","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]},{"raw_affiliation_string":"PDX Pharmaceuticals, Inc., Portland, OR, USA. yantasee@ohsu.edu","institution_ids":[]},{"raw_affiliation_string":"Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5083234239"],"corresponding_institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"],"apc_list":{"value":5890,"currency":"USD","value_usd":5890},"apc_paid":{"value":5890,"currency":"USD","value_usd":5890},"fwci":18.048,"has_fulltext":true,"cited_by_count":225,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99618362,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"13","issue":"1","first_page":"4261","last_page":"4261"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.13220000267028809,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7990000247955322},{"id":"https://openalex.org/keywords/plk1","display_name":"PLK1","score":0.8529999852180481},{"id":"https://openalex.org/keywords/volasertib","display_name":"volasertib","score":0.968999981880188},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5950000286102295},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7720000147819519},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.4560000002384186},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.6679999828338623},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8820000290870667}],"concepts":[{"id":"https://openalex.org/C146276462","wikidata":"https://www.wikidata.org/wiki/Q21131841","display_name":"PLK1","level":4,"score":0.7087994813919067},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6544630527496338},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6290600895881653},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6148033142089844},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5695608854293823},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48460209369659424},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4487265646457672},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4282481074333191},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40733063220977783},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2930734157562256},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.19545698165893555},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.18342271447181702},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16488897800445557}],"mesh":[{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1038/s41467-022-31926-9","doi":"https://doi.org/10.1038/s41467-022-31926-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-31926-9","pdf_url":"https://www.nature.com/articles/s41467-022-31926-9.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-142908/v2","doi":"https://doi.org/10.21203/rs.3.rs-142908/v2","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-142908/v2","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"doi:10.21203/rs.3.rs-142908/v1","doi":"https://doi.org/10.21203/rs.3.rs-142908/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-142908/v1","pdf_url":"https://www.researchsquare.com/article/rs-142908/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:9308817","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9308817/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nat Commun","raw_type":"Text"},{"id":"pmid:35871223","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35871223","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature communications","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31926-9","doi":null,"is_oa":false,"landing_page_url":"https://www.nature.com/articles/s41467-022-31926-9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:47471679aa7f42218b940fed0ac3e8d9","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/47471679aa7f42218b940fed0ac3e8d9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41467-022-31926-9","doi":"https://doi.org/10.1038/s41467-022-31926-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-31926-9","pdf_url":"https://www.nature.com/articles/s41467-022-31926-9.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1634881414","display_name":"Development of topical formulation of siRNA-nanoparticle for treating skin diseases","funder_award_id":"R43TR001906","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1746974112","display_name":"Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer","funder_award_id":"R44CA217534","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3268057301","display_name":"Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer","funder_award_id":"R44CA265751","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4097162655","display_name":"In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response","funder_award_id":"R44CA265752","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309233","display_name":"Oregon Health and Science University","ror":"https://ror.org/009avj582"},{"id":"https://openalex.org/F4320310169","display_name":"University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320334223","display_name":"Knight Cancer Institute, Oregon Health and Science University","ror":"https://ror.org/002shna07"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4286742004.pdf","grobid_xml":"https://content.openalex.org/works/W4286742004.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W1518200290","https://openalex.org/W1834322579","https://openalex.org/W1889335134","https://openalex.org/W1928807762","https://openalex.org/W1987027200","https://openalex.org/W1991235944","https://openalex.org/W1996863944","https://openalex.org/W2026274426","https://openalex.org/W2029827106","https://openalex.org/W2036238945","https://openalex.org/W2037117428","https://openalex.org/W2038660811","https://openalex.org/W2040146704","https://openalex.org/W2044626782","https://openalex.org/W2049553585","https://openalex.org/W2056528509","https://openalex.org/W2076452801","https://openalex.org/W2127019295","https://openalex.org/W2136394786","https://openalex.org/W2158558808","https://openalex.org/W2175767930","https://openalex.org/W2177804157","https://openalex.org/W2254524854","https://openalex.org/W2275249742","https://openalex.org/W2275389390","https://openalex.org/W2292383635","https://openalex.org/W2346025119","https://openalex.org/W2464405525","https://openalex.org/W2467902526","https://openalex.org/W2527905628","https://openalex.org/W2533688214","https://openalex.org/W2549761003","https://openalex.org/W2560367415","https://openalex.org/W2580398445","https://openalex.org/W2587333476","https://openalex.org/W2608165987","https://openalex.org/W2769376007","https://openalex.org/W2784012638","https://openalex.org/W2795043036","https://openalex.org/W2804845336","https://openalex.org/W2805114969","https://openalex.org/W2847455257","https://openalex.org/W2890139110","https://openalex.org/W2890262057","https://openalex.org/W2898915459","https://openalex.org/W2902609075","https://openalex.org/W2914668539","https://openalex.org/W2918171974","https://openalex.org/W2921653938","https://openalex.org/W2939342954","https://openalex.org/W2943232183","https://openalex.org/W2975926349","https://openalex.org/W2997724502","https://openalex.org/W3014043586","https://openalex.org/W3168587734","https://openalex.org/W4210291751","https://openalex.org/W4211236050"],"related_works":["https://openalex.org/W4362595626","https://openalex.org/W4412987562","https://openalex.org/W4407901998","https://openalex.org/W4405733387","https://openalex.org/W4313400350","https://openalex.org/W4386121705","https://openalex.org/W4214574115","https://openalex.org/W4399665496","https://openalex.org/W7118452754","https://openalex.org/W4289204829"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitors":[2],"(ICIs)":[3],"targeting":[4],"PD-L1":[5,60,71,100,124],"and":[6,51,70,87,98,123,135,161],"PD-1":[7,162],"have":[8],"improved":[9],"survival":[10],"in":[11,82,102,113,128,149],"a":[12,25,43,64,75,114,129,168],"subset":[13],"of":[14,27,59,92,121],"patients":[15,29],"with":[16],"advanced":[17],"non-small":[18],"cell":[19],"lung":[20,131,151],"cancer":[21,89,96,104],"(NSCLC).":[22],"However,":[23],"only":[24],"minority":[26],"NSCLC":[28,86],"respond":[30,158],"to":[31,55,159,172],"ICIs,":[32],"highlighting":[33],"the":[34,57,136],"need":[35],"for":[36,109],"superior":[37],"immunotherapy.":[38],"Herein,":[39],"we":[40],"report":[41],"on":[42],"nanoparticle-based":[44],"immunotherapy":[45],"termed":[46],"ARAC":[47,62,110,117,145],"(Antigen":[48],"Release":[49],"Agent":[50],"Checkpoint":[52],"Inhibitor)":[53],"designed":[54],"enhance":[56],"efficacy":[58,148],"inhibitor.":[61],"is":[63,74,80,138],"nanoparticle":[65,179],"co-delivering":[66],"PLK1":[67,73,93],"inhibitor":[68,163],"(volasertib)":[69],"antibody.":[72],"key":[76],"mitotic":[77],"kinase":[78],"that":[79,181],"overexpressed":[81],"various":[83],"cancers":[84],"including":[85],"drives":[88],"growth.":[90],"Inhibition":[91],"selectively":[94],"kills":[95],"cells":[97,105],"upregulates":[99],"expression":[101],"surviving":[103],"thereby":[106],"providing":[107],"opportunity":[108],"targeted":[111],"delivery":[112],"feedforward":[115],"manner.":[116],"reduces":[118],"effective":[119],"doses":[120],"volasertib":[122],"antibody":[125],"by":[126,141,176],"5-fold":[127],"metastatic":[130],"tumor":[132,152],"model":[133,153],"(LLC-JSP)":[134],"effect":[137],"mainly":[139],"mediated":[140],"CD8+":[142],"T":[143],"cells.":[144],"also":[146],"shows":[147],"another":[150],"(KLN-205),":[154],"which":[155],"does":[156],"not":[157],"CTLA-4":[160],"combination.":[164],"This":[165],"study":[166],"highlights":[167],"rational":[169],"combination":[170],"strategy":[171],"augment":[173],"existing":[174],"therapies":[175],"utilizing":[177],"our":[178],"platform":[180],"can":[182],"load":[183],"multiple":[184],"cargo":[185],"types":[186],"at":[187],"once.":[188]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4286742004","counts_by_year":[{"year":2026,"cited_by_count":46},{"year":2025,"cited_by_count":67},{"year":2024,"cited_by_count":52},{"year":2023,"cited_by_count":49},{"year":2022,"cited_by_count":11}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2022-07-23T00:00:00"}
